Cargando…
Health state utility valuation in radioactive iodine-refractory differentiated thyroid cancer
PURPOSE: The aim of this study was to elicit utilities for radioactive iodine-refractory differentiated thyroid cancer (RR-DTC) and evaluate the impact of treatment response and toxicities on quality of life. PATIENTS AND METHODS: RR-DTC health states were developed based on data from a previous qua...
Autores principales: | Fordham, Beth A, Kerr, Cicely, de Freitas, Hayley M, Lloyd, Andrew J, Johnston, Karissa, Pelletier, Corey L, Tremblay, Gabriel, Forsythe, Anna, McIver, Bryan, Cohen, Ezra EW |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4639528/ https://www.ncbi.nlm.nih.gov/pubmed/26604709 http://dx.doi.org/10.2147/PPA.S90425 |
Ejemplares similares
-
Treatment patterns, health state, and health care resource utilization of patients with radioactive iodine refractory differentiated thyroid cancer
por: Gianoukakis, Andrew G, et al.
Publicado: (2016) -
Quantitative thyroglobulin response to radioactive iodine treatment in predicting radioactive iodine-refractory thyroid cancer with pulmonary metastasis
por: Wang, Chen, et al.
Publicado: (2017) -
Identification of Radioactive Iodine Refractory Differentiated Thyroid Cancer
por: Mu, Zhuan-Zhuan, et al.
Publicado: (2019) -
Radioactive Iodine-Refractory Differentiated Thyroid Cancer and Redifferentiation Therapy
por: Liu, Jierui, et al.
Publicado: (2019) -
Reproducibility of radioactive iodine uptake (RAIU) measurements
por: Pelletier‐Galarneau, Matthieu, et al.
Publicado: (2017)